Atea Pharmaceuticals, Inc. · NASDAQ:AVIR
Radoff Bradley Louis reported a 3.30% stake in Atea Pharmaceuticals, Inc. (Schedule 13D)
Event Feb 27, 2025 · Filed Mar 4, 2025
Radoff Bradley Louis reported a 3.30% stake in Atea Pharmaceuticals, Inc., 2,820,000 shares, with active intent on Feb 27, 2025. Filed Mar 4, 2025 (Schedule 13D).
- Stake
- 3.30%
- Shares
- 2,820,000
- Intent
- Active
- What changed
- Crossed above 5%
- Filed together
- 6 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Radoff Family Foundation | 0.20% | 165,000 |
| Radoff Bradley Louis | 3.30% | 2,820,000 |
| JEC II Associates, LLC | 1.50% | 1,300,000 |
| The MOS Trust | 0.10% | 100,000 |
| MOS PTC, LLC | 0.10% | 100,000 |
| Torok Michael | 1.80% | 1,500,000 |
Source
Related
- Atea Pharmaceuticals, Inc.
- Radoff Bradley Louis
- Atea Pharmaceuticals, Inc. shareholders
- Schedule 13D/A · Radoff Bradley Louis · Apr 17, 2025
- Schedule 13D/A · Radoff Bradley Louis · Mar 21, 2025
- Schedule 13G · Tang Capital Management LLC · Oct 6, 2026
- Form 4 · Lucidi Bruno · Jun 23, 2026
- Form 4 · Berger Franklin M · Jun 23, 2026
- Form 4 · Duncan Barbara Gayle · Jun 23, 2026
- Form 4 · Adams Jerome M. · Jun 23, 2026